| |
| |
|
| Insider
Information: |
Rote William E. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
80,720 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$497,235 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
80,720 |
|
|
| Total
Value |
$497,235 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 12.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
80,720 |
2017-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2017-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,985 |
12,190 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
17,656 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2018-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
22,992 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
19,810 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
27,185 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,250 |
28,896 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
27,086 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
29,086 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
39,582 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,582 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
41,832 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
37,138 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
40,895 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,840 |
46,360 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,250 |
62,626 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
62,988 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SENIOR VICE PRESIDENT, R&D |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
85,484 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-05-11 |
4 |
AS |
$14.95 |
$12,154 |
D/D |
(813) |
24,833 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2023-05-10 |
4 |
AS |
$16.59 |
$13,687 |
D/D |
(825) |
59,211 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2019-05-15 |
4 |
AS |
$17.76 |
$14,421 |
D/D |
(812) |
18,185 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2019-05-14 |
4 |
AS |
$17.78 |
$14,455 |
D/D |
(813) |
18,997 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SENIOR VICE PRESIDENT, R&D |
• – – |
2024-01-23 |
4 |
AS |
$8.96 |
$18,476 |
D/D |
(2,062) |
60,484 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-02-18 |
4 |
AS |
$16.55 |
$20,688 |
D/D |
(1,250) |
25,646 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Senior Vice President, R&D |
• – – |
2020-02-14 |
4 |
AS |
$16.72 |
$20,900 |
D/D |
(1,250) |
26,896 |
0 |
% |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
